Library
home (Home) TU Delft Repository login Login

Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile

Journal Article (2018)
Author(s)

Frank Vrieling (Leiden University Medical Center)

Katharina Ronacher (University of Queensland, Stellenbosch University)

Léanie Kleynhans (Stellenbosch University)

Erik van den Akker (TU Delft - Electrical Engineering, Mathematics and Computer Science, Leiden University Medical Center)

Gerhard Walzl (Stellenbosch University)

Tom H.M. Ottenhoff (Leiden University Medical Center)

Simone A. Joosten (Leiden University Medical Center)

Research Group
Pattern Recognition and Bioinformatics
DOI related publication
https://doi.org/10.1016/j.ebiom.2018.05.011 Final published version
More Info
expand_more
Publication Year
2018
Language
English
Research Group
Pattern Recognition and Bioinformatics
Volume number
32
Pages (from-to)
192-200
Downloads counter
230
Collections
Institutional Repository
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract


Background: Type 2 diabetes mellitus (DM) is a major risk factor for development of tuberculosis (TB), however the underlying molecular foundations are unclear. Since lipids play a central role in the development of both DM and TB, lipid metabolism may be important for TB-DM pathophysiology. Methods: A
1
H NMR spectroscopy-based platform was used to determine 225 lipid and other metabolic intermediates in plasma samples of healthy controls (n = 50) and patients with TB (n = 50), DM (n = 50) or TB-DM (n = 27). Results: TB patients presented with wasting disease, represented by decreased amino acid levels including histidine and alanine. Conversely, DM patients were dyslipidemic as evidenced by high levels of very low-density lipoprotein triglycerides and low high-density lipoprotein cholesterol. TB-DM patients displayed metabolic characteristics of both wasting and dyslipidemia combined with disease interaction-specific increases in phospholipid metabolites (e.g. sphingomyelins) and atherogenic remnant-like lipoprotein particles. Biomarker analysis identified the ratios of phenylalanine/histidine and esterified cholesterol/sphingomyelin as markers for TB classification regardless of DM-status. Conclusions: TB-DM patients possess a distinctive plasma lipid profile with pro-atherogenic properties. These findings support further research on the benefits of improved blood lipid control in the treatment of TB-DM.